Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy

Date Published April 20, 2026

West Neuroscience, Neurology and Cognitive Disorders
Examining if selective calpain-2 inhibition prevents seizure-induced hippocampal neuropathology in mice.

This work investigates the role of calpain-2 activation in seizure-induced neuropathology using mouse models of epilepsy. The study employed conditional calpain-2 knock-out (C2CKO) mice on a C57/Bl6 background and a selective calpain-2 inhibitor to dissect the contribution of prolonged calpain-2 activity to downstream pathological events following kainic acid (KA)-induced seizures. In C57/Bl6 mice 7 days after KA-induced seizures, marked neurodegeneration was evident across hippocampal subfields, with particular vulnerability of mossy cells in the hilus of the dentate gyrus. Notably, calpain-2 activation persisted in mossy cells at this 7-day time point, implicating sustained calpain-2 activity in the evolution of post-seizure neuropathology.

In contrast, mice lacking calpain-2 (C2CKO) and C57/Bl6 mice treated with a selective calpain-2 inhibitor for the week following seizure initiation did not show calpain activation, astroglial and microglial activation, neurodegeneration, or cognitive impairment. These findings indicate that calpain-2 activation is necessary for several hallmark pathological processes that follow status epilepticus in this model. The investigators also examined molecular substrates of calpain-2–mediated damage and found that levels of the potassium chloride cotransporter 2 (KCC2) were decreased in mossy cells 7 days after seizures; importantly, this decrease in KCC2 was prevented either by calpain-2 genetic deletion or by selective pharmacological inhibition. The preservation of KCC2 suggests a plausible mechanistic link between calpain-2 activity and impaired ion homeostasis or inhibitory signaling after seizures, mechanisms that could contribute to both neuronal degeneration and functional deficits.

Collectively, the experiments presented demonstrate that prolonged calpain-2 activation plays a critical role in neuropathology following seizures, affecting neuronal survival, glial activation, molecular regulators of neuronal function, and cognitive outcomes. The parallel protective effects observed with genetic deletion and with a selective calpain-2 inhibitor support the specificity of calpain-2’s contribution and indicate that pharmacological targeting of calpain-2 has translational potential. The authors conclude that a selective calpain-2 inhibitor could represent a therapeutic approach to mitigate seizure-induced neuropathology.

These results, reported in Neurobiology of Disease, provide preclinical evidence that calpain-2 is a key mediator of post-seizure brain injury in this mouse model and justify further exploration of selective calpain-2 inhibition as a strategy to prevent or reduce the long-term neurological consequences of severe seizures.

Update This Listing

Help us provide the most up-to-date information about this project.

Contact Us
Questions?

For questions about these research projects please email us.

Contact Us
This summary was generated by AACOM. The researchers and authors of this work were not involved in the curation of this summary.